Literature DB >> 21297728

Diagnosis and management of involutional osteoporosis.

P M Hodsman.   

Abstract

Of postmenopausal women, 20-30% will experience symptomatic involutional osteoporosis. Though the cause is still poorly defined, recent information gives the family physician several routes to treat effectively most patients who become symptomatic. Two other responsibilities exist, however: defining occult causes for the porotic process which may be of greater importance than the osteoporosis itself, and attempting to treat patients at risk for future osteoporosis prophylactically. The latter is a task where we have very effective modes of therapy, but we are only just beginning to develop means of defining that populace destined to suffer from future osteoporosis.

Entities:  

Year:  1979        PMID: 21297728      PMCID: PMC2383039     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  50 in total

1.  Increased risk of endometrial carcinoma among users of conjugated estrogens.

Authors:  H K Ziel; W D Finkle
Journal:  N Engl J Med       Date:  1975-12-04       Impact factor: 91.245

2.  Histological studies of bone from normocalcemic post-menopausal osteoporotic patients with increased circulating parathyroid hormone.

Authors:  S L Teitelbaum; E M Rosenberg; C A Richardson; L V Avioli
Journal:  J Clin Endocrinol Metab       Date:  1976-03       Impact factor: 5.958

3.  Effects of calcium infusions in patients with postmenopausal osteoporosis.

Authors:  J Walton; M Dominquez; F C Bartter
Journal:  Metabolism       Date:  1975-07       Impact factor: 8.694

4.  Osteoporosis of the slender smoker. Vertebral compression fractures and loss of metacarpal cortex in relation to postmenopausal cigarette smoking and lack of obesity.

Authors:  H W Daniell
Journal:  Arch Intern Med       Date:  1976-03

5.  Geographical variations in senile osteoporosis. The association with physical activity.

Authors:  J Chalmers; K C Ho
Journal:  J Bone Joint Surg Br       Date:  1970-11

6.  Long-term prevention of postmenopausal osteoporosis by oestrogen. Evidence for an increased bone mass after delayed onset of oestrogen treatment.

Authors:  R Lindsay; D M Hart; J M Aitken; E B MacDonald; J B Anderson; A C Clarke
Journal:  Lancet       Date:  1976-05-15       Impact factor: 79.321

7.  Preventive effect of estrogen on postmenopausal bone loss.

Authors:  S Meema; M L Bunker; H E Meema
Journal:  Arch Intern Med       Date:  1975-11

8.  Treatment of osteoporosis of ageing with 1alpha-hydroxycholecalciferol.

Authors:  B Lund; L Hjorth; I Kjaer; I Reimann; T Friis; R B Andersen; O H Sorensen
Journal:  Lancet       Date:  1975-12-13       Impact factor: 79.321

Review 9.  Senile and postmenopausal osteoporosis.

Authors:  L V Avioli
Journal:  Adv Intern Med       Date:  1976

10.  Association of exogenous estrogen and endometrial carcinoma.

Authors:  D C Smith; R Prentice; D J Thompson; W L Herrmann
Journal:  N Engl J Med       Date:  1975-12-04       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.